Abstract
Introduction:
Cerebellar dysplasia with cysts (CDC) is an imaging finding which is typically seen with in individuals with dystroglycanopathy. One of the diseases causing this condition is “Poretti-Boltshauser Syndrome; PTBHS” (OMIM #615960). Homozygous or compound heterozygous mutations in the LAMA1 gene cause this disease.
Case presentation:
7 years old twin siblings consulted to the medical genetics department because of walking problems and cerebellar examination findings.
Management and Outcome:
Clinical and radiological findings of the patient suggested a syndrome with recessive inheritance. Whole exome sequencing (WES) test was performed for definitive diagnosis. As a result of the patient’s WES analysis, a homozygous mutation was detected in the LAMA1 gene.
Discussion:
When determining the inheritance pattern of genetic diseases, if parents have consanquinity, this situation leads us to recessive inheritance diseases. Even if we are not consanquinity, but they say the same village, it is necessary to pay attention to the diseases of the recessive group. Whole exome sequencing analysis results in large amount of data generation. A good clinical evaluation is required to detect the mutation as a result of large data. To understand what we have found, we need to know what we are looking for.
Keywords: Cerebellar vermis, cerebellar ataxia, laminin
Introduction
Cerebellar malformations cause defective development of the cerebellum and often manifest itself in the first months of life. For some cerebellar malformations, neuroimaging findings are specific and provide diagnosis of disease.1 However, imaging findings of other cerebellar malformations such as hypoplasia, dysplasia, and cysts are less specific for the disease in which they are components.2,3 In 2014, “Poretti-Boltshauser Syndrome; PTBHS” (OMIM #615960) is defined by cerebellar cyst and cerebellar dysplasia.4 This disease also causes myopia with or without retinal dystrophy.
Laminins connect basal membranes and extracellular matrix to cell and these are heterotrimeric glycoproteins. At the same time their function is to provide the integrity of the tissue.5 Of the 12 genes, 9 encoding the laminin subunits are associated with the disease in human.6-8 One of these genes is the LAMA1 gene encoding Laminin alpha-1. The mutation in this gene causes congenital muscular dystrophy group diseases. In 2014, in the study by Aldinger et al., homozygous or compound heterozygous mutations in this gene were reported to cause “PTBHS.”4
This disease is very rare. A total of 31 cases (we think 2 of them are repeated and same cases and therefore total number may be 29) of PTBHS have been reported in 4 publications.4,9-13 In this case report, we aimed to present the clinical findings of the siblings with homozygous mutations in the LAMA1 gene that caused PTBHS.
Case Presentation
Twin boys aged 7 years consulted the medical genetics department with walking problem and cerebellar examination findings. Anamnesis information, examination findings, laboratory results, and genetic test results of twins are summarized in the following.
Patient 1
He was born at 38 weeks of gestation as 2300 g. The 5-minute APGAR score was 8 to 9 points. He started walking at 2 years. At physical examination, head circumference, height, and weight were between 10 and 25 percentile. At the dysmorphic examination, narrow face, pointed chin, hypertelorism, telecanthus, macrotia, smooth philtrum, and thin upper lip vermillion were found. Hypokinesia and dysmetria were detected in the cerebellar examination of the patient. Also, he had ataxia when walking. At ophthalmic examination, he had normal fundus and he had no visual problems. The pathological findings at magnetic resonance imaging (MRI) of the patient are as follows: multiple cysts in millimetric dimensions at both cerebellar hemispheres, irregularities in the cerebellum cortex, cerebellar vermis hypoplasia, and enlargement at fourth ventricle (Figures 1 and 2).
Figure 1.

Brain MR images show cerebellar cyst and enlarged forth ventricle. MR indicates magnetic resonance.
Figure 2.

Brain MR images show cerebellar cyst. MR indicates magnetic resonance.
Patient 2
In the prenatal period, encephalocele was detected in the seventh month of pregnancy. He was born at 38 weeks of gestation as 1900 g. The 5-minute APGAR score was 6 to 7 points. The encephalocele was excised at 16th day postnatal. The brain tissue and optic nerve were also located in this sac, so these structures were excised too. Hence, he is blind. He had ventriculoperitoneal shunt operation at the ninth month. When he was 5 years old, Botox was injected at the ankles because of spasticity in the lower extremities and tension in the Achilles tendon. He cannot walk still. At physical examination of the patient, his head circumference, height, and weight were under 3 percentile. He had microcephaly. His neck movement had limited extension. At the upper and lower extremities, he had spasticity. At the dysmorphic examination, narrow face, malar flattening, hypertelorism, upslanted palpebral fissure, telecanthus, macrotia, smooth philtrum, and thin upper lip vermillion were found. At ophthalmic examination, he had pale optic disk at the temporal regions in both eyes and he cannot see. At his cranial computed tomography, it was observed that lateral ventricles and third ventricular were collapsed.
The parents of these twin siblings have no consanguinity, but they are from the same village.
Whole exome sequencing (WES) was performed. As a result of this analysis, the homozygous NM_005559.4 c.8192C>A (p.S2731*) (p. Ser2731Ter) VCV000372974.1 in the LAMA1 gene was detected (ClinVar ID is RCV000413473.1). This mutation is classified as disease causing in MutationTaster and the allele frequency is 0.0000159. In the analysis of the parents, the same mutation was resulted as heterozygous and these were again confirmed by Sanger sequencing. According to the American College of Medical Genetics (ACMG) criteria, this mutation has been reported as “pathogenic.” This is called “PTBHS” (OMIM #615960). Because of the genotype-phenotype similarity of the patients in the literature and our patients, we decided that the diagnosis was PTBHS. Thus, the definitive diagnosis was provided for twin brothers.
Additional informed consent was obtained from all individual participants for whom identifying information is included in this article. Ethical approval is not required at our institution to publish an anonymous case report.
Discussion
A total of 12 cases were reported in three publications for PTBHS (summarized in Table 1). Previously, in the study of Micalizz et al., PTBHS patients from Turkey have been reported. We did not include Table 1 because they did not evaluate patients one by one in their articles. In addition, Table 2 summarizes the clinical and MRI findings of patients including the study of Micalizzi et al.
Table 1.
Summary of the literature of the cases of Poretti-Boltshauser Syndrome and our cases.
| Aldinger et al4 | Vilboux et al10 | Marlow et al11 | Masson et al12 | Banerjee et al13 | Our Cases | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P1 | P2 | P3 | P4 | P5 | P6 | P7 | P1 | P2 | P3 | P1 | P2 | P1 | P1 | P1 | P2 | |
| Age | 36 months | 36 months | 25 months | 29 years | 23 years | 5.5 years | 4.5 years | 21 years | 26 years | 8,5 years | Younger than 5 years | Younger than 5 years | 30 months | 2.5 years | 7 years | 7 years |
| Sex | Female | Female | Male | Female | Male | Female | Female | Male | Female | Female | Female | Male | Female | Male | Male | Male |
| In LAMA1 gene | ||||||||||||||||
| Zygosity | Homozygous | Compound heterozygous | Compound heterozygous | Compound heterozygous | Compound heterozygous | Compound heterozygous | Compound heterozygous | Compound heterozygous | Compound heterozygous | Compound heterozygous | Compound heterozygous | Compound heterozygous | Compound heterozygous | Homozygous | Homozygous | Homozygous |
| Mutation | c.588+2T>G | c.6345+3G>C (maternal) and deletion of exons 4-11 (paternal) | c.7965-15_7965-3del (paternal) and c.2988_2989delA (maternal) | c.6701delC (paternal) and c.8557-1G>C, c.768+1G>A (maternal) | c.6701delC (paternal) and c.8557-1G>C, c.768+1G>A (maternal) | c.2816_2817delAT (paternal) and c.555T>G (maternal) | c.2816_2817delAT (paternal) and c.555T>G (maternal) | c.6701delC (paternal) and c.768+1G>A, c.8557–1G>C (maternal) | c.6701delC (paternal) and c.768+1G>A, c.8557–1G>C (maternal) | c.2160T>A (maternal) and c.5985_5991del (paternal) | c.664C>T and c.2331C>G | c.664C>T and c.2331C>G | — | c.4702_4703del | c.8192C>A | c.8192C>A |
| Protein change | Canonical splice | Splice and NA | Splice and p.Pro996Hisfs28* | p.Pro2334Leufs9* and splice, splice | p.Pro2334Leufs9* and splice, splice | p.Tyr939Leufs27* and p.Tyr185* | p.Tyr939Leufs27* and p.Tyr185* | Canonical splice and Pro2234Leufs*9 | Canonical splice and Pro2234Leufs*9 | p.Cys720* and p.Ile1996Glufs*7 | p.Arg222* and p.Tyr777* | p.Arg222* and p.Tyr777* | p.R2921* and exon 62-63 deletion | p.(Leu1568Glyfs*2) | (p.S2731*) (p. Ser2731Ter) | (p.S2731*) (p.Ser2731Ter) |
| Ethnicity | Iranian | Mixed European | Mixed European | Mixed European | Mixed European | Asian and African American | Asian and African American | Unknown | Unknown | Caucasian and Native American | Unknown | Unknown | Caucasian | Unknown | Turkish | Turkish |
| Occipitofrontal circumference | 50th percentile | >98th percentile | 20th percentile | 50th percentile | 30th percentile | 35th percentile | 35th percentile | Normal | Normal | Unknown | Unknown | Unknown | Unknown | <3 percentile | 10-25 percentile | <3 percentile |
| Neurodevelopmental features | Moderate motor and speech delay | Moderate motor delay (no standing or walking), mild speech delay | Motor delay (cruising, but no walking), hypotonia | History of motor delay, normal speech, normal IQ, college graduate, lives independently | History of motor and speech delay, normal IQ, autism spectrum disorder (Asperger), lives with parents | Mild motor and speech delay, hypotonia | Motor and speech delay, hypotonia | History of motor and speech delay, graduated high school, mildly wide-based gait | Mild motor and speech delays, mildly wide-based gait, graduated from high school | Delayed motor development | Delayed | Delayed | Mild motor delay | Delayed | Mild motor delay, hypokinesia and dysmetria | Mild motor and speech delays |
| Ataxia | Unknown | Unknown | Unknown | Unknown | Unknown | Unknown | Unknown | + | + | + | Unknown | Unknown | + | + | + | Unknown |
| Autistic features | − | − | − | − | − | − | − | − | − | − | Unknown | Unknown | + | Unknown | − | − |
| Strabismus | + | + | + | + | + | − | + | + | + | Unknown | Unknown | − | Unknown | + | ||
| Brain MRI | ||||||||||||||||
| Cerebellar dysplasia | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | The patient has no MRI |
| Cerebellar cysts | + | + | + | + | + | − | − | + | + | + | + | + | + | + | + | |
| Vermis hypoplasia | Global | Global | Global | Global | Global | Inferior only | Inferior only | + | + | Global | − | − | + | − | + | |
| Superior cerebellar peduncles | Elevated and splayed | Elevated and splayed | Normal | Elevated and splayed | Elevated and splayed | Normal | Slightly elevated | Normal | Normal | Normal | Atrophic | Atrophic | Normal | − | Normal | |
| Fourth ventricle | Enlarged | Enlarged | Enlarged | Enlarged | Enlarged | Mildly enlarged | Normal | Enlarged | Enlarged | Normal | Enlarged | Enlarged | Enlarged | Enlarged | Enlarged | |
| Brainstem | Short pons, thin isthmus | Short pons, long midbrain, mildly enlarged tectum | Normal | Thin isthmus | Thin isthmus | Mass effect from arachnoid cyst | Normal | Midbrain is mildly elongated, pons is mildly reduced | Elongated midbrain and pons and appearing small | Normal | Normal | Normal | Normal | Unknown | Normal | |
| Ventricles | Normal | Moderate ventriculomegaly, partial agenesis of corpus callosum and septum pellucidum | Normal | Normal | Normal | Normal | Normal | Normal | Normal | Normal | Normal | Normal | Normal | Unknown | Normal | |
| Increased T2/FLAIR in white matter | Patchy increased, periventricular | Patchy increased, periventricular | Normal | Normal | Normal | Patchy increased, periventricular | Normal | Normal | Normal | Normal | Normal | Normal | Normal | Bilateral peritrigonal periventricular white matter changes | Normal | |
| Other | Atrophic retina, aminoaciduria, consanguinity | Thinned retina, seizure | Absent pigment at retina | Lattice and peripheral degeneration at retina, macular heterotopia, increased pigment at retina, fatty liver on ultrasound, syndactyly in second and third toes | Atrophic retina, bilateral cataracts, echogenic liver on ultrasound, syndactyly in second and third toes | Retinal dysfunction: cones more affected than rods | Chorioretinal atrophy, macular and peripheral involvement, cones worse than rods | Retinal dystrophy, high myopia, shoulder shrugging and nose wrinkling tics, bilateral syndactyly of the second and third toes | Shoulder shrugging and nose wrinkling, bilateral syndactyly of the second and third toes | Peripheral lattice degeneration of retina and bilateral arm extensions and flexions, nose wrinkling tics | High myopia | High myopia | Head titubation, occasional motor stereotypes, ocular motor apraxia | Myopia | Normal | Encephalocele, spasticity, pale optic disk |
Abbreviation: MRI, magnetic resonance imaging.
Table 2.
Clinical and MRI features of cases reported as PTBHS (including our twin patients).
| Features | Number of patients (%) |
|---|---|
| Sex (female) | 16 of 33 (48) |
| Ataxia | 22 of 33 (67) |
| Strabismus | 17 of 33 (52) |
| Neurodevelopmental delay | 32 of 33 (97) |
| Myopia | 12 of 33 (36) |
| Retinal dystrophy | 15 of 33 (45) |
| Cerebellar dysplasia | 32 of 33 (97) |
| Cerebellar cysts | 31 of 33 (94) |
| Enlarged fourth ventricle | 27 of 33 (82) |
| Abnormal brainstem | 15 of 33 (45) |
Abbreviation: PTBHS, Poretti-Boltshauser Syndrome; MRI, magnetic resonance imaging.
Previously, cases who are siblings have been reported, but identical twins cases have not been reported and encephalocele finding was also not previously reported in any cases. That may be wrong to think that LAMA1 gene mutation may be the possible cause of encephalocele finding in P2. Because there is an increased risk of congenital cranial malformations in twin cases.14,15
The compound heterozygous mutation is mostly observed. Previously, only one case reported had a homozygous mutation. At that case, consanguinity between parents was reported. Homozygous mutation was found in our cases too, but their parents had no consanguinity between. However, they were born in the same village. This situation suggests that they have consanguinity from distant ancestors. Therefore, it is very important to ask the patients where their parents are from. Because if they are from the same village, recessive inheritance disease should be considered.
At eye examination, most of the patients were found to have eye findings. At the eye examination, in one of our patients, any findings were found (P1). The possible cause of this condition can be considered as this mutation damage eyes less than other mutations. The probable cause of ocular finding in the other twin is encephalocele which develops during intrauterine period.
All mutations in a gene that cause a disease do not cause the same clinical findings due to mechanisms such as allelic heterogeneity and variable expressivity in genetic diseases. As shown in Table 1, the age at which PTBHS patients are diagnosed is on a wide range from 25 months to 29 years. The mean age of the patients presented in Table 1 (except our patient) was 10.10. In addition, Micalizzi et al. reported that the average age of follow-up of 17 patients with PTBHS was 7.2 years.9 MRI findings are present in almost all patients. However, eye examination findings and clinical findings such as ataxia and microcephaly were not reported in all the patients. This situation is an example for a genetic disease that causes a variety of clinical effects even in mutations in the same gene. As seen in our twin patients, although they have the same mutation but their severity for disease are different. Patients with mild clinical findings or with rare clinical findings in the disease may be challenging in diagnosis. In such a case, WES may be a preferable test.
Conclusions
The penetrance of all genetic diseases is different. This makes the diagnosis difficult. it is important to know the patient’s clinical history very well and to evaluate the patient in a multidisciplinary manner.
Acknowledgments
We thank our patient for agreeing to this report and sharing their insights on the genetic counselling experience.
Footnotes
Funding:The author(s) received no financial support for the research, authorship, and/or publication of this article.
Declaration of Conflicting Interests:The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Author Contributions: ME conceived and designed the study. BG performed clinical assessments. ME performed experiments and contributed to data acquisition, analysis, and interpretation. BG and MS drafted the manuscript. All authors contributed to critical revision of the manuscript for intellectual content and final approval of the manuscript.
Consent for Publication: Written informed consent was obtained from the patient’s parents for publication of this case report. A copy of the written consent is available for review by the Editor-in-Chief of this journal. The family and patient agree to publish this paper and have read and approved the final version of this manuscript including photos of the patient.
Ethical Approval: Ethical approval is not required at our institution to publish an anonymous case report.
ORCID iD: Muhsin Elmas
https://orcid.org/0000-0002-5626-2160
References
- 1. Bosemani T, Orman G, Boltshauser E, Tekes A, Huisman TAGM, Poretti A. Congenital abnormalities of the posterior fossa. Radiographics. 2015;35:200-220. doi: 10.1148/rg.351140038. [DOI] [PubMed] [Google Scholar]
- 2. Boltshauser E, Scheer I, Huisman TAGM, Poretti A. Cerebellar cysts in children: a pattern recognition approach. Cerebellum. 2015;14:308-316. doi: 10.1007/s12311-014-0633-9. [DOI] [PubMed] [Google Scholar]
- 3. Poretti A, Boltshauser E, Doherty D. Cerebellar hypoplasia: differential diagnosis and diagnostic approach. Am J Med Genet C Semin Med Genet. 2014;166C:211-226. doi: 10.1002/ajmg.c.31398. [DOI] [PubMed] [Google Scholar]
- 4. Dempsey JC, Aldinger KA, Mosca SJ, et al. Mutations in LAMA1 cause cerebellar dysplasia and cysts with and without retinal dystrophy. Am J Hum Genet. 2014;95:227-234. doi: 10.1016/j.ajhg.2014.07.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Li S, Liquari P, McKee KK, et al. Laminin-sulfatide binding initiates basement membrane assembly and enables receptor signaling in Schwann cells and fibroblasts. J Cell Biol. 2005;169:179-189. doi: 10.1083/jcb.200501098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Sewry CA, Philpot J, Mahony D, Wilson LA, Muntoni F, Dubowitz V. Expression of laminin subunits in congenital muscular dystrophy. Neuromuscul Disord. 1995;5:307-316. [DOI] [PubMed] [Google Scholar]
- 7. Hasselbacher K, Wiggins RC, Matejas V, et al. Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders. Kidney Int. 2006;70:1008-1012. doi: 10.1038/sj.ki.5001679. [DOI] [PubMed] [Google Scholar]
- 8. Mundegar RR, von Oertzen J, Zierz S. Increased laminin A expression in regenerating myofibers in neuromuscular disorders. Muscle Nerve. 1995;18:992-999. doi: 10.1002/mus.880180911. [DOI] [PubMed] [Google Scholar]
- 9. Micalizzi A, Poretti A, Romani M, et al. Clinical, neuroradiological and molecular characterization of cerebellar dysplasia with cysts (Poretti-Boltshauser syndrome). Eur J Hum Genet. 2016;24:1262-1267. doi: 10.1038/ejhg.2016.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Vilboux T, Malicdan MCV, Chang YM, et al. Cystic cerebellar dysplasia and biallelic LAMA1 mutations: a lamininopathy associated with tics, obsessive compulsive traits and myopia due to cell adhesion and migration defects. J Med Genet. 2016;53:318-329. doi: 10.1136/jmedgenet-2015-103416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Marlow E, Chan RVP, Oltra E, Rusu I, Gupta MP. Retinal avascularity and neovascularization associated with LAMA1 (laminin1) mutation in Poretti-Boltshauser syndrome. JAMA Ophthalmol. 2018;136:96-97. doi: 10.1001/jamaophthalmol.2017.5060. [DOI] [PubMed] [Google Scholar]
- 12. Masson R, Piretti E, Pellegrin S, et al. Early-onset head titubation in a child with Poretti-Boltshauser syndrome. Neurology. 2017;88:1478-1479. doi: 10.1212/WNL.0000000000003823. [DOI] [PubMed] [Google Scholar]
- 13. Banerjee A, Vyas S, Sankhyan N. Cerebellar cysts and dysplasias: more diagnoses to consider. Pediatr Neurol. 2019;98:91-92. doi: 10.1016/j.pediatrneurol.2019.02.021. [DOI] [PubMed] [Google Scholar]
- 14. Sepulveda W, Wong AE, Andreeva E, Odegova N. Sonographic spectrum of first-trimester fetal cephalocele: review of 35 cases. Ultrasound Obstet Gynecol. 2015;46:29-33. doi: 10.1002/uog.14661. [DOI] [PubMed] [Google Scholar]
- 15. Kar A, Nanda S, Kar T, Dhal I, Satpathy BP, Mohapatra K. Prevalence and spectrum of congenital anomalies in multiple births with analysis of demographic and obstetric risk factors. Obstet Gynecol. 2018;12:5-9. doi: 10.7860/JCDR/2018/32531.12032. [DOI] [Google Scholar]
